Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study

Blood Pressure
Ingjerd W MannerIngrid Os

Abstract

Hypertension is a significant contributor to cardiovascular disease in HIV-infected individuals. The purposes of this study were to assess the development of new-onset hypertension and the use of antihypertensive treatment and blood pressure (BP) control. In a longitudinal study of 434 HIV-infected individuals (43±11 years, 72% males, follow-up 3.4±0.8 years), standardized BP recordings were undertaken at three clinical visits both at baseline and at follow-up, and cardiovascular risk factors were monitored. Adjusted odds ratio (OR) for new-onset hypertension (systolic BP≥140 and/or diastolic BP≥90 mmHg or initiation of antihypertensive treatment) was calculated using multiple logistic regression analyses. New-onset hypertension occurred with an incidence of 29.8 per 1000 person-years (95% CI 20.3-42.2). HIV duration (OR=1.10, 95% CI 1.01-1.20), mean BP (1.24, 95% CI 1.13-1.35) and abnormal urinary albumin excretion (OR=5.47, 95% CI 1.07-27.85) were independent predictors for new-onset hypertension after adjustment. Use of antihypertensive treatment increased threefold from 17% to 49% in hypertensive patients. Adequate BP control was obtained in 22% of patients on antihypertensive therapy. HIV duration predicted new-onset hyper...Continue Reading

References

May 24, 2001·AIDS·A M CattelanP Cadrobbi
Jul 19, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith S CurrierSally Hodder
Oct 10, 2003·Advances in Cardiology·Daniel VittecoqGilles Chironi
Nov 12, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B M BergersenJ N Bruun
Nov 25, 2003·The New England Journal of Medicine·Nina Friis-MøllerUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
Dec 11, 2003·JAMA : the Journal of the American Medical Association·Howard D SessoPaul M Ridker
Jul 9, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Oliver JungHelmut Geiger
Nov 11, 2005·American Journal of Hypertension·Carlos JericóJuan Pedro-Botet
Apr 26, 2007·The Journal of Clinical Endocrinology and Metabolism·Virginia A TriantSteven K Grinspoon
Apr 27, 2007·The New England Journal of Medicine·UNKNOWN DAD Study GroupJens D Lundgren
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Niels ObelJan Gerstoft
Nov 6, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ian GrahamUNKNOWN European Atherosclerosis Society (EAS)
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Apr 24, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Virginia A TriantSteven K Grinspoon
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Dec 19, 2009·American Journal of Hypertension·Camilla AsfergJørgen Jeppesen
May 8, 2010·The Journal of Infectious Diseases·Jacqueline NeuhausJames D Neaton
Jun 3, 2010·Antiviral Therapy·Franck BoccaraMartine Caron-Debarle
Jul 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth A LichtensteinUNKNOWN HIV Outpatient Study (HOPS) Investigators
Aug 12, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amanda MocroftUNKNOWN EuroSIDA Study Group
Dec 15, 2010·Hypertension·David G HarrisonCornelia M Weyand
May 5, 2011·JAMA : the Journal of the American Medical Association·Katarzyna Stolarz-SkrzypekUNKNOWN European Project on Genes in Hypertension (EPOGH) Investigators

❮ Previous
Next ❯

Citations

Oct 1, 2013·American Journal of Hypertension·Giuseppe Vittorio De SocioUNKNOWN CISAI Study Group
Jan 24, 2013·The Journal of Clinical Hypertension·Ingjerd W MannerIngrid Os
May 5, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rosan A van ZoestUNKNOWN AGEhIV Cohort Study Group
Apr 5, 2013·Therapeutic Advances in Chronic Disease·Elyse J SingerMargrit Carlson
Apr 11, 2018·Journal of Hypertension·Ashita S BataviaRobert N Peck
Aug 9, 2017·Current Opinion in HIV and AIDS·Rosan A van ZoestPeter Reiss
Jun 6, 2017·European Journal of Preventive Cardiology·Rosan A van ZoestUNKNOWN AGEhIV Cohort Study Group
Jun 6, 2019·Current Hypertension Reports·Sepiso K MasengaAnnet Kirabo
Oct 31, 2020·The Journal of Clinical Hypertension·Fred Stephen SarfoBruce Ovbiagele
Mar 6, 2021·Journal of Clinical Pharmacy and Therapeutics·Idongesit L Jackson, Chinwe V Ukwe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.